L N Kubicek - JoVE Visualize

Showing results (1-10 of 2) with videos related to

Pageof 1

Sort By:

Veterinary and Comparative Oncology|January 13, 2012

Safety evaluation of combination toceranib phosphate (Palladia®) and piroxicam in tumour-bearing dogs (excluding mast cell tumours): a phase I dose-finding studyE Chon, L McCartan, L N Kubicek, et al.

Veterinary and Comparative Oncology|February 24, 2015

Patient characteristics influencing the variability of distributed parameter-based models in DCE-CT kinetic analysisM D La Fontaine, L S McDaniel, L N Kubicek, et al.

Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:

Pageof 1

Veterinary and Comparative Oncology|January 13, 2012

Safety evaluation of combination toceranib phosphate (Palladia®) and piroxicam in tumour-bearing dogs (excluding mast cell tumours): a phase I dose-finding studyE Chon, L McCartan, L N Kubicek, et al.

Veterinary and Comparative Oncology|February 24, 2015

Patient characteristics influencing the variability of distributed parameter-based models in DCE-CT kinetic analysisM D La Fontaine, L S McDaniel, L N Kubicek, et al.

Pageof 1